Inhibitory Effect of BCG Cell-Wall Skeletons (BCG-CWS) Emulsified in Squalane on Tumor Growth and Metastasis in Mice

  • Yoo, Yung-Choon (Department of Microbiology, College of Medicine, Konyang University) ;
  • Hata, Katsusuke (Institute of Immunological Science, Hokkaido University) ;
  • Lee, Kyung-Bok (Department of Biochemistry, College of Medicine, Konyang University) ;
  • Azuma, Ichiro (Institute of Immunological Science, Hokkaido University, Hokkaido National College of Technology)
  • Published : 2002.08.01

Abstract

The antimetastatic effect of BCG-CWS, which was emulsified in an oil-in-water form with either Drakeol 6VR mineral oil (BCG-CWS/DK) or squalane (BCG-CWS/SQA), on lung metastasis produced by highly metastatic murine tumor cells, Colon26-M3.1 carcinoma cells and B16-BL6 melanoma cells, was investigated in syngeneic mice. An intravenous (i.v.) administration of BCG-CWS (100 mg/mouse) 1 day after tumor inoculation significantly inhibited tumor metastasis of both Colon26-M3.1 carcinoma and B16-BL6 melanoma cells in experimental lung metastasis models. No differences in the antitumor activity of the two oil-based formulations (BCG-CWS/DK and BCG-CWS/SQA) were obverved. However, BCG-CWS/SQA administered through subcutaneous (s.c.) route was shown to be effective only when it was consecutively injected (3 times) after tumor inoculation. An in vivo analysis for tumor-induced angiogenesis shwed that a single i.v. administration of BCG-CWS/SQA inhibited the number of tumor-induced blood vessels and suppressed tumor growth. Furthermore, the multiple administration of BCG-CWS/SQA given at on week intervals led to a significant reduction in spontaneous lung metastasis of B16-BL6 melanoma cells in a spontaneous metastasis model. These results suggest that BCG-CWS emulsified with squalane is a potent inhibitory agent of lung metastasis, and that the anti metastatic effect of BCG-CWS is related to the suppression of tumor growth and the inhibition of tumor-induced angiogenesis.

Keywords

References

  1. Azuma, I., Kishimoto, S., Yamamura, Y, and Petit, J.F., Adjuvanticity of mycobacterial cell walls. Jpn. J. Microbiol., 15, 193-197 (1971) https://doi.org/10.1111/j.1348-0421.1971.tb00569.x
  2. Azuma, I., Ribi, E.E., Meyer, T.J., and Zber, B., Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton andcomponent P3. J. Natl. Cancer Inst., 52, 95-101 (1974) https://doi.org/10.1093/jnci/52.1.95
  3. Azuma, I. and Yamamura, Y., Immunotherapy of cancer with BCG cell-wall skeleton and related materials. Gann Monogr. Cilncer Res., 24, 121-141 (1979)
  4. Bingham, E., Stemmer, K.L., and Falk, H.L., The effects of repeated injections of certain adjuvants on chemical carcinogenesis. Ann. Allergy, 25, 684-690 (1967)
  5. Fidler, I.J., Selection of successive tumour lines for metastasis. Nat. New BioI., 242, 148-149 (1973) https://doi.org/10.1038/newbio242148a0
  6. Freund, J., The mode of action of immunological adjuvants. Adv. Tuberc. Res., 7, 130-148 (1956)
  7. Han, M.J., Park, H.Y., and Kim, D.H., Pretective effects of Bifidobacterium spp. on experimental colon carcinigenesis wih 1,2-dimethylhydrazine. J. Microbiol. Biotechnol., 9, 368-370 (1999)
  8. Hayashi, A., Interferon-g as a marker for the effective cancer immunotherapy with BCG-cell wall skeleton. Proc. Japan Acad,. 70, 205-209 (1994) https://doi.org/10.2183/pjab.70.205
  9. Hayashi, A., and Noda, A., Does the cell wall skeleton from Bacille Calmette-Guerin directly induce interferon-g, independent of interleukin-12? Jpn. J. Clin. Oncol., 26, 124-127 (1996) https://doi.org/10.1093/oxfordjournals.jjco.a023194
  10. Hirao, F., Nishikawa, H., Yasaki, S., Ogura, T., Azuma, I.,Taniyama, T., Yoshimoto, T., Kishimoto, S., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton and thymectomy on the incidence of lung cancer and amyloidosis induced by chemical carcinogens in rabbits. Gann, 69, 453-459 (1978)
  11. Kang, T.Y., Park, S.H., and Choe, T.B., Immunostimulating effects of cell wall components isolated from Lactobacillus plantarum. J. Microbiol. Biotechnol., 4, 195-199 (1994)
  12. Kuwamura, S., Studies on the relationship between the induction of primary hepatic carcinoma by 3'-methyl-4-dimethylaminoazobenzene and cell-mediated immunity in hosts. J. Osaka City Med. Cent,. 26, 145-157 (1977)
  13. Matsumoto, M., Seya, T., Kikkawa, S., Tsuji, S., Shida, K., Nomura, M., Kurita-Taniguchi, M., Ohigashi H., Yokouchi, H.,Takami, H., Hayashi, A., Azuma, I., Masaoka, T., Kodama, K., and Toyoshima, K., Interferon gamma-producing activity in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. Int. Immunopharmacol., 1(8), 1559-1569 (2001) https://doi.org/10.1016/S1567-5769(01)00071-6
  14. Ogura, T., Namba, M., Hirao, F., Yamawaki, M., Azuma, I., and Yamamura Y., Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping. Gann, 69, 311-315 (1978)
  15. Okuyama, H. and Morikawa, K., Histological study on adjuvanticity of BCG-cell wall: Comparison of adjuvanticity between oil-in-water and water-in-oil forms. GANN Monogr. Cancer Res., 21, 87-91 (1978)
  16. Tokuzen, R., Okabe, M., Nakahara, W., Azuma, I., and Yamamura, Y., Effect of Nocardia and Mycobacterium cell-wall skeletons on autochthonous tumor grafts. Gann, 66, 433-435 (1975)
  17. Whitehouse, M.W., Orr, K.J., Beck, F.W., and Pearson, C., Freund's Adjuvants: Relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology, 27, 311-330 (1974)
  18. Yoo, Y.C., Saiki, I., Sato, K., and Azuma, I., MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumors in mice. Vaccine, 12, 175-180 (1994) https://doi.org/10.1016/0264-410X(94)90057-4
  19. Yoo, Y.C., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., and Azuma, I., Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res., 88, 184-19 (1997) https://doi.org/10.1111/j.1349-7006.1997.tb00364.x
  20. Yoo, Y.C., Park, S.Y., Lee, K.B., and Azuma, I., MDP-Lys(L18), a synthetic muramyl dipeptide derivative, enhances antitumor activity of an inactivated tumor vaccine. J. Microbiol. Biotechnol., 10, 399-404 (2000)
  21. Yoshimoto, T., Azuma, I., Sakatani, M., Nishikawa, H., Ogura, T, Hirao, F., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcoma in mice. Gann, 67, 441-445 (1976)